Article
The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase.
Nature medicine - 1 May 2015
Vicuña Lucas, Strochlic David E, Latremoliere Alban, Bali Kiran Kumar, Simonetti Manuela, Husainie Dewi, Prokosch Sandra, Riva Priscilla, Griffin Robert S, Njoo Christian, Gehrig Stefanie, Mall Marcus A, Arnold Bernd, Devor Marshall, Woolf Clifford J, Liberles Stephen D, Costigan Michael, Kuner Rohini
Abstract excerpt
Neuropathic pain is a major, intractable clinical problem and its pathophysiology is not well understood. Although recent gene expression profiling studies have enabled the identification of novel targets for pain therapy, classical study designs provide unclear results owing to the differential expression of hundreds of genes across sham and nerve-injured groups, which can be difficult to validate, particularly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
